1. Inflammation Research Association proceedings of the sixth international conference

   • Douglas W. Morgan
   • Ann F. Welton

   Editorial Pages: C3 - C3

2. Interleukin-1β induces cytosolic PLA₂ in parallel with prostaglandin E₂ in rheumatoid synovial fibroblasts

   • Keren I. Hulkower
   • John W. Coffey
   • Douglas W. Morgan

   Lipid Mediators Pages: C5 - C7

3. Inflammatory mediator changes in cotton-top tamarins (CTT) after SC-41930 anti-colitic therapy

   • N. Clapp
   • M. Henke
   • D. Fretland

   Lipid Mediators Pages: C8 - C10

4. The design and synthesis of second generation leukotriene B₄ (LTB₄) receptor antagonists related to SC-41930

   • T. D. Penning
   • S. W. Djuric
   • D. L. Widomski

   Lipid Mediators Pages: C11 - C13

5. Identification of phospholipase D (PLD) activity in mouse peritoneal macrophages

   • J. E. Meats
   • L. Steele
   • J. G. Bowen

   Lipid Mediators Pages: C14 - C16

6. Platelet activating factor modulates peptidoleukotriene effects on the permeability of bovine aortic endothelial cell to albumin

   • M. G. Sirois
   • G. E. Plante
   • P. Sirois

   Lipid Mediators Pages: C17 - C20

7. Effects of chronic NSAIDs on gastric mucosal injury related to mucosal prostanoids, and plasma drug concentrations in human volunteers

   • K. D. Rainsford
   • C. James
   • R. H. Hunt

   Drugs and Lipid Mediators Pages: C21 - C23

8. Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage

   • K. D. Rainsford

   Drugs and Lipid Mediators Pages: C24 - C26

9. Analgesic activities of PEM-420, the active eutomer of pemedolac

   • T. Chau
   • T. Walter
   • B. Weichman

   Drugs and Lipid Mediators Pages: C27 - C29

10. Pharmacological characterization of WAY-121,520: A potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A₂ (PLA₂)

    • K. B. Glaser
    • R. P. Carlson
    • B. M. Weichman

    Drugs and Lipid Mediators Pages: C30 - C32

11. Structure-activity relationships leading to WAY-121,520, a tris aryl-type, indomethacin-based, phospholipase A₂ (PLA₂)/leukotriene biosynthesis inhibitor

    • A. Kreft
    • J. Nelson
    • K. Glaser

    Drugs and Lipid Mediators Pages: C33 - C35

12. Anti-colitic efficacy of SC-41930 in colitic cotton-top tamarins

    • N. Clapp
    • M. Henke
    • D. Fretland

    Drugs and Lipid Mediators Pages: C36 - C38

13. Secretory phospholipase A₂ inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A₂

    • William C. Hope
    • Ting Chen
    • Douglas W. Morgan

    Drugs and Lipid Mediators Pages: C39 - C42

14. Effect of 5-lipoxygenase inhibitors onin situ LTB₄ biosynthesis following calcium ionophore stimulation in the rat pleural cavity

    • A. Raychaudhuri
    • H. Chertock
    • G. DiPasquale

    Drugs and Lipid Mediators Pages: C43 - C45

15. Effect of anti-inflammatory compounds on edema formation and myeloperoxidase activity in the arachidonic acid-induced ear model in the mouse

    • B. Kotyuk
    • A. Raychaudhuri
    • G. DiPasquale

    Drugs and Lipid Mediators Pages: C46 - C48

16. Anti-inflammatory properties and inhibition of leukotriene C₄ biosynthesisin vitro by flavonoid baicalein fromScutellaria baicalensis georgy roots

    • I. G. Butenko
    • S. V. Gladtchenko
    • S. V. Galushko

    Drugs and Lipid Mediators Pages: C49 - C51

17. Inhibition of endotoxin-induced hypothermia and serum TNF-α levels in CD-1 mice by various pharmacological agents

    • S. J. Ochalski
    • D. A. Hartman
    • R. P. Carlson

    Regulation of Cytokinses Pages: C52 - C54

18. Effects of pyridinyl imidazole compounds on murine TNF-α production

    • D. L. Olivera
    • J. T. Laydon
    • J. C. Lee

    Regulation of Cytokinses Pages: C55 - C57

19. Adjuvant arthritic (AA) rats exhibit enhanced endotoxin-induced plasma TNF (EIPT) levels

    • M. DiMartino
    • M. Slivjak
    • R. Gagnon

    Regulation of Cytokinses Pages: C58 - C60

20. Tumour necrosis factor α production by rat blood and itsex vivo pharmacological modulation

    • S. J. Foster
    • L. M. McCormick

    Regulation of Cytokinses Pages: C61 - C63

21. Inhibition of interleukin-1 (IL-1) and tumor necrosis factor (TNF) production by pyridinyl imidazole compounds is independent of cAMP elevating mechanisms

    • S. Kassis
    • U. Prabhakar
    • J. C. Lee

    Regulation of Cytokinses Pages: C64 - C66

22. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level

    • P. Young
    • P. McDonnell
    • J. Lee

    Regulation of Cytokinses Pages: C67 - C69

23. The effects of anti-inflammatory and antiallergic drugs on the release of IL-1β and TNF-α in the human whole blood assay

    • D. A. Hartman
    • S. J. Ochalski
    • R. P. Carlson

    Regulation of Cytokinses Pages: C70 - C72

24. Effect of protein kinase inhibitors on IL-8/NAP-1 release from human umbilical vein endothelial cells

    • John R. White
    • John C. Lee

    Regulation of Cytokinses Pages: C73 - C76

25. Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors

    • K. Molnar-Kimber
    • L. Yonno
    • B. Weichman

    Regulation of Cytokinses Pages: C77 - C79

26. The leukocyte recruitment inhibitor, NPC 15669 accelerates healing in acetic acid-induced colitis

    • V. C. Lowe
    • L. Noronha-Blob

    Immunoregulation Pages: C80 - C82

27. Prevention and suppression of experimental allergic encephalomyelitis by an orally active leukocyte recruitment inhibitor, NPC 16570

    • V. C. Lowe
    • L. Noronha-Blob

    Immunoregulation Pages: C83 - C85

28. Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470

    • A. E. Berger
    • K. A. Dortch
    • M. S. Holm

    Immunoregulation Pages: C86 - C88

29. Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cells

    • G. M. Lewis
    • R. G. Caccese
    • C. C. Bansbach

    Immunoregulation Pages: C89 - C92

30. The effects of several diphosphonates on murine bone marrow proliferation

    • K. A. Richard
    • N. D. Staite

    Immunoregulation Pages: C93 - C95

31. PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. I. Suppression of the human mixed lymphocyte reaction (MLR)

    • David J. Wilburn
    • Mi K. Dong
    • Richard B. Gilbertsen

    Immunoregulation Pages: C96 - C98

32. PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat bloodin vitro

    • Mi K. Dong
    • Richard B. Gilbertsen

    Immunoregulation Pages: C99 - C101

33. Coagulation effects of cyclosporine in liver transplantation

    • R. J. Ferrante
    • C. R. Spillert
    • E. J. Lazaro

    Immunoregulation Pages: C102 - C103

34. Prothrombotic effects of endothelin-2 (ET-2)

    • G. W. Raff
    • C. R. Spillert
    • E. J. Lazaro

    Immunoregulation Pages: C104 - C105

35. Procoagulant property of platelet activating factor (PAF)

    • G. W. Raff
    • C. R. Spillert
    • E. J. Lazaro

    Immunoregulation Pages: C106 - C106

36. Impaired activity of thiol-dependent ATPases in rheumatoid mononuclear cell membranes

    • K. Maubach
    • A. D. Foey
    • N. D. Hall

    Immunoregulation Pages: C107 - C109

37. Suppressive effects of a novel antioxidant compound on human T cell functionsin vitro

    • J. K. Kalsi
    • K. Clay
    • N. D. Hall

    Immunoregulation Pages: C110 - C112

38. Immunomodulatory activity of recombinant IL-1 receptor (IL-1-R) on models of experimental rheumatoid arthritis

    • H. U. Schorlemmer
    • E. J. Kanzy
    • R. Kurrle

    Immunoregulation Pages: C113 - C116

39. Immunoregulation of SLE-like disease by the IL-1 receptor: Disease modifying activity on BDF1 hybrid mice and MRL autoimmune mice

    • H. U. Schorlemmer
    • E. J. Kanzy
    • R. Kurrle

    Immunoregulation Pages: C117 - C120

40. Immunosuppressive therapy of organ-specific nephritic autoimmune diseases with 15-deoxyspergualin

    • H. U. Schorlemmer
    • H. P. Neubauer
    • G. Dickneite

    Immunoregulation Pages: C121 - C124

41. Additive effects of a bradykinin antagonist, NPC 17761, and a leumedin, NPC 15669, on survival in animal models of sepsis

    • L. Otterbein
    • V. C. Lowe
    • L. Noronha-Blob

    Lung Inflammation Pages: C125 - C127

42. Sulfuric acid induces airway hyperresponsiveness to substance P in the guinea pig

    • Peter W. Stengel
    • Alison M. Bendele
    • Steven A. Silbaugh

    Lung Inflammation Pages: C128 - C131

43. Human eosinophil major basic protein augments bronchoconstriction induced by intravenous agonists in guinea pigs

    • S. N. Desai
    • G. Van
    • T. C. Noonan

    Lung Inflammation Pages: C132 - C135

44. Effect of the 21-aminosteroid, U-74389F, on hyperoxic lung injury in rats

    • I. M. Richards
    • R. L. Griffin
    • E. J. Jacobsen

    Lung Inflammation Pages: 136 - 138

45. Rapamycin inhibits airway leukocyte infiltration and hyperreactivity in guinea pigs

    • J. N. Francischi
    • D. Conroy
    • P. Sirois

    Lung Inflammation Pages: C139 - C141

46. l-glutamate activates peripheral nociceptors

    • B. Ault
    • L. M. Hildebrand

    Lung Inflammation Pages: C142 - C144

47. A proposed autacoid mechanism controlling mastocyte behaviour

    • Luigi Aloe
    • Alberta Leon
    • Rita Levi-Montalcini

    Lung Inflammation Pages: C145 - C147

48. Peptides based on the conserved prodomain sequence of matrix metalloproteinases inhibit human stromelysin and collagenase

    • A. C. Hanglow
    • A. Lugo
    • N. Fotouhi

    Osteoarthritis Pages: C148 - C150

49. A stromelysin assay for the assessment of metalloprotease inhibitors on human aggregated proteoglycan

    • J. R. Doughty
    • R. L. Goldberg
    • G. Di Pasquale

    Osteoarthritis Pages: C151 - C153

50. Sensitivity of monoclonal antibody, 5-D-4, for the detection of aggrecan, aggrecan fragments, and keratan sulfate

    • C. A. Saphos
    • P. Dey
    • V. L. Moore

    Osteoarthritis Pages: C154 - C156